Social engagement
Social engagement: 467 social following, 1 post in the last 12 months — below the industry typical range.
Investor mix
1 investor on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 100% |
Developing ophthalmic anti-viral drugs for adenoviral conjunctivitis (pink eye)
Social engagement: 467 social following, 1 post in the last 12 months — below the industry typical range.
1 investor on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 100% |